U.S. state attorneys general said on Thursday that Johnson & Johnson and its unit had agreed to pay nearly US$117 million to settle litigation over deceptive marketing of the company’s transvaginal surgical mesh devices.
Recent Posts
Most Popular
Lower rates, surging stock market fail to ignite US IPO market
PUBLIC listings on Wall Street have seen a slow comeback in 2024 despite a resilient US economy, a long-awaited interest rate cut...